Western Season with Epidemic Flu, SARS-CoV-2 Omicron Strains and hRSV
DOI:
https://doi.org/10.14738/bjhmr.102.14548Keywords:
Flu virus, SARS-CoV-2, hRSV, Influenza, VaccineAbstract
Last Fall/Winter season there was not only the ghost of COVID-19 in circulation, but many other respiratory microbic agents were present with the return of influenza viruses and of the RSV, also it is worthy to mention the adenoviruses family and even the streptococcus haemolytic. The main reason of this paper is the description of what happened with the final goal to be prepared for an early diagnosis and a prompt therapy that put in primis the prevention with specific vaccines when there is the possibility.
References
Tarro G. The Epidemy of Bronchiolotis in Children. Messina Medica 2.0. January 9, 2023.
Tarro G. Epidemic Flu Viruses. EC Microbiology 15.4 (2019): 304-308.
Collie S and Nayager J. Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa. New Engl J Med 387;14. Ocotber 6, 2022.
Malato J, Gomes MC and Graca L. Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants. New Engl J Med 387;10. September 8, 2022.
Tarro G. On the End of a Nightmare (COVID-19). The Role of the Immune System. British Journal of Healthcare and Medical Research - Vol. 9, No. 6. December, 25, 2022.
Zimmer SM and Burke DS. “Historical perspective--Emergence of influenza A (H1N1) viruses”. New England Journal of Medicine 361.3 (2009): 279-285.
Enserink M, Cohen J (2009) Virus of the year. The novel H1N1 influenza. Science 326: 1607.
Tarro G, Esposito C. emerging viral agents at risk in global health approaches to early diagnosis and prompt therapy. International Conference on Bioinformatics and Computational Biology. CS Red Press. Las Vegas USA 2011.
Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. ) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674-679, 2009.
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615,
Lister P, Reynolds F, Parslow R, Chan A, Cooper M, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 374: 605-607, 2009.
ANZIC Influenza Investigators: Webb SA, Pettilä V, Seppelt I, Bellomo R, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361: 1925-1934, 2009.
Centers for Disease Control and Prevention (CDC) Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR Morb Mortal Wkly Rep 58: 826-82, 2009.
Esposito C, Di Spirito A, Cuomo N, Tarro G et al. Tracking the 2009 H1N1 Influenza Virus in the Italian Region Campania. Journal of Cellular Physiology. Vol 227: 2813-2817, July 2012.
Tarro G. Analyzing the risk of Flu for understanding a better prevention. International Conference on Flu. Chicago, USA June 8-10 2015.
Tarro G. Emerging Influenza Viruses at Risk in Global Health. 2nd International Conference on Flu. San Francisco, USA, November 28-30, 2016. Tarro, G. (2023). Western Season with Epidemic Flu, SARS-CoV-2 Omicron Strains and hRSV. British Journal of Healthcare and Medical Research,
23. Tarro G. Emerging H1N1 Influenza A Virus and its Specific Prevention. 13th Annual Congress on Vaccines, Therapeutics & Travel Medicine: Influenza and Infectious Disease, Atlanta, USA, December 01/02, 2016.
Tarro G. Enviroment and Virus Interctions: Towards a Systematic Therapy of SARS-CoV-2. British Journal of Healthcare and Medical Research - Vol. 9, No. 4 August, 25, 2022.
Tarro G. Pros and Cons of COVID-19 Vaccines. British Journal of Healthcare and Medical Research - Vol. 10, No. 1 February 25, 2023.
Tarro G. Priorities and Threats of Antibiotic Resistance. British Journal of Healthcare and Medical Research - Vol. 10, No. 2 April 5, 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Giulio Tarro
This work is licensed under a Creative Commons Attribution 4.0 International License.
